Google parent company Alphabet Inc. has launched a new company in London called Isomorphic Labs. The company aims to use AI (artificial intelligence) for drug discovery and medicine to find cures for some of humanity’s most devastating diseases. Demis Hassabis will be the CEO of Isomorphic Labs. Hassabis is the CEO and co-founder of DeepMind, another Alphabet subsidiary that used AI to predict the 3D structure of a protein directly from its amino acid sequence.
The London-based Isomorphic Labs will work on the most important applications of AI — in the field of biological and medical research. The company aims to use AI to accelerate drug discovery, and ultimately, find cures for some of humanity’s most devastating diseases. The new venture also plans to partner with biomedical and pharmaceutical companies, using artificial intelligence to discover new medicinal advancements.
Important takeaways for all competitive exams
Bondi Beach is one of Australia’s most recognisable and loved coastal destinations. Located just minutes…
As one of the all-time great WWE superstars, John Cena officially retired from in-ring competition…
The Indian Space Research Organisation (ISRO) has revealed plans for no less than seven space…
The Chakrashila Wildlife Sanctuary in Assam has recently come into focus due to successful community-led…
India’s presence in global motorsport technology received a major boost as MRF Tyres clinched the…
India's push towards meeting its increasing energy demands while ensuring long-term sustainability received a boost…